FI60408C - Foerfarande foer framstaellning av vaccin mot parvovirus-panleukopeni hos felider - Google Patents
Foerfarande foer framstaellning av vaccin mot parvovirus-panleukopeni hos felider Download PDFInfo
- Publication number
- FI60408C FI60408C FI770181A FI770181A FI60408C FI 60408 C FI60408 C FI 60408C FI 770181 A FI770181 A FI 770181A FI 770181 A FI770181 A FI 770181A FI 60408 C FI60408 C FI 60408C
- Authority
- FI
- Finland
- Prior art keywords
- virus
- cats
- vaccine
- panleucopenia
- cell
- Prior art date
Links
- 241000700605 Viruses Species 0.000 description 50
- 241000282326 Felis catus Species 0.000 description 48
- 229960005486 vaccine Drugs 0.000 description 43
- 210000004027 cell Anatomy 0.000 description 25
- 241001465754 Metazoa Species 0.000 description 21
- 239000000243 solution Substances 0.000 description 19
- 241000282324 Felis Species 0.000 description 18
- 238000002474 experimental method Methods 0.000 description 18
- 238000004113 cell culture Methods 0.000 description 16
- 238000002255 vaccination Methods 0.000 description 15
- 208000015181 infectious disease Diseases 0.000 description 14
- 210000003292 kidney cell Anatomy 0.000 description 14
- 239000002609 medium Substances 0.000 description 13
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- 230000002238 attenuated effect Effects 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 210000000265 leukocyte Anatomy 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- 210000003754 fetus Anatomy 0.000 description 8
- 235000015097 nutrients Nutrition 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 238000004820 blood count Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 102000004142 Trypsin Human genes 0.000 description 5
- 108090000631 Trypsin Proteins 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 239000012588 trypsin Substances 0.000 description 5
- 239000005862 Whey Substances 0.000 description 4
- 102000007544 Whey Proteins Human genes 0.000 description 4
- 108010046377 Whey Proteins Proteins 0.000 description 4
- 244000309466 calf Species 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 102000004407 Lactalbumin Human genes 0.000 description 3
- 108090000942 Lactalbumin Proteins 0.000 description 3
- 206010035148 Plague Diseases 0.000 description 3
- 241000607479 Yersinia pestis Species 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000004114 suspension culture Methods 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 241000700198 Cavia Species 0.000 description 2
- 241000701925 Feline parvovirus Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 241000125945 Protoparvovirus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241001455214 Acinonyx jubatus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000282341 Mustela putorius furo Species 0.000 description 1
- 241000282331 Mustelidae Species 0.000 description 1
- RSPISYXLHRIGJD-UHFFFAOYSA-N OOOO Chemical compound OOOO RSPISYXLHRIGJD-UHFFFAOYSA-N 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000006727 cell loss Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Flanged Joints, Insulating Joints, And Other Joints (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2602478A DE2602478C3 (de) | 1976-01-23 | 1976-01-23 | Impfstoff gegen die Panleukopenie der Feliden |
| DE2602478 | 1976-01-23 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI770181A7 FI770181A7 (OSRAM) | 1977-07-24 |
| FI60408B FI60408B (fi) | 1981-09-30 |
| FI60408C true FI60408C (fi) | 1982-01-11 |
Family
ID=5968104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI770181A FI60408C (fi) | 1976-01-23 | 1977-01-20 | Foerfarande foer framstaellning av vaccin mot parvovirus-panleukopeni hos felider |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4312947A (OSRAM) |
| AT (1) | AT360147B (OSRAM) |
| BE (1) | BE850696A (OSRAM) |
| CH (1) | CH629962A5 (OSRAM) |
| DE (1) | DE2602478C3 (OSRAM) |
| DK (1) | DK147033C (OSRAM) |
| ES (2) | ES455137A1 (OSRAM) |
| FI (1) | FI60408C (OSRAM) |
| FR (1) | FR2338708A1 (OSRAM) |
| GB (1) | GB1576223A (OSRAM) |
| IE (1) | IE44691B1 (OSRAM) |
| IT (1) | IT1076012B (OSRAM) |
| LU (1) | LU76616A1 (OSRAM) |
| NL (1) | NL7700482A (OSRAM) |
| NO (2) | NO152936C (OSRAM) |
| PT (1) | PT66097B (OSRAM) |
| SE (1) | SE426550B (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2702634A1 (de) * | 1977-01-22 | 1978-07-27 | Behringwerke Ag | Verfahren zur herstellung einer vaccine gegen die panleukopenie der katze |
| DE2962920D1 (en) * | 1978-11-30 | 1982-07-08 | Wellcome Found | Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it |
| US4193990A (en) * | 1979-02-16 | 1980-03-18 | Cornell Research Foundation, Inc. | Heterotypic canine parvovirus vaccine |
| US4711778A (en) * | 1980-07-30 | 1987-12-08 | Norden Laboratories, Inc. | Inactivated rabies vaccine for veterinary use |
| US5820869A (en) * | 1995-06-07 | 1998-10-13 | American Home Products Corporation | Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL300960A (OSRAM) * | 1962-11-27 | |||
| GB1177635A (en) * | 1966-02-18 | 1970-01-14 | Wellcome Found | Cell Stains. |
| US3892627A (en) * | 1973-06-04 | 1975-07-01 | Rohm & Haas | Feline panleukopenia vaccine |
-
1976
- 1976-01-23 DE DE2602478A patent/DE2602478C3/de not_active Expired
-
1977
- 1977-01-18 ES ES455137A patent/ES455137A1/es not_active Expired
- 1977-01-18 NL NL7700482A patent/NL7700482A/xx not_active Application Discontinuation
- 1977-01-20 FI FI770181A patent/FI60408C/fi not_active IP Right Cessation
- 1977-01-21 CH CH76477A patent/CH629962A5/de not_active IP Right Cessation
- 1977-01-21 NO NO770208A patent/NO152936C/no unknown
- 1977-01-21 PT PT66097A patent/PT66097B/pt unknown
- 1977-01-21 AT AT38277A patent/AT360147B/de not_active IP Right Cessation
- 1977-01-21 IE IE127/77A patent/IE44691B1/en unknown
- 1977-01-21 SE SE7700652A patent/SE426550B/xx not_active IP Right Cessation
- 1977-01-21 LU LU76616A patent/LU76616A1/xx unknown
- 1977-01-21 IT IT19537/77A patent/IT1076012B/it active
- 1977-01-21 FR FR7701805A patent/FR2338708A1/fr active Granted
- 1977-01-21 DK DK24977A patent/DK147033C/da not_active IP Right Cessation
- 1977-01-21 US US05/761,438 patent/US4312947A/en not_active Expired - Lifetime
- 1977-01-24 BE BE174334A patent/BE850696A/xx unknown
- 1977-01-24 GB GB2713/77A patent/GB1576223A/en not_active Expired
- 1977-05-19 ES ES458954A patent/ES458954A1/es not_active Expired
- 1977-06-15 NO NO772101A patent/NO152937C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH629962A5 (de) | 1982-05-28 |
| NL7700482A (nl) | 1977-07-26 |
| GB1576223A (en) | 1980-10-01 |
| NO152937C (no) | 1985-12-18 |
| IE44691L (en) | 1977-07-23 |
| US4312947A (en) | 1982-01-26 |
| BE850696A (fr) | 1977-07-25 |
| NO152937B (no) | 1985-09-09 |
| DK147033C (da) | 1984-09-03 |
| ES458954A1 (es) | 1978-07-16 |
| NO770208L (no) | 1977-07-26 |
| AT360147B (de) | 1980-12-29 |
| PT66097A (de) | 1977-02-01 |
| DE2602478B2 (de) | 1980-01-31 |
| NO772101L (no) | 1977-07-26 |
| DE2602478C3 (de) | 1980-10-09 |
| NO152936B (no) | 1985-09-09 |
| DE2602478A1 (de) | 1977-07-28 |
| SE7700652L (sv) | 1977-07-24 |
| IE44691B1 (en) | 1982-02-24 |
| FR2338708B1 (OSRAM) | 1980-03-28 |
| DK24977A (da) | 1977-07-24 |
| FI60408B (fi) | 1981-09-30 |
| NO152936C (no) | 1985-12-18 |
| DK147033B (da) | 1984-03-26 |
| FI770181A7 (OSRAM) | 1977-07-24 |
| PT66097B (de) | 1978-08-03 |
| IT1076012B (it) | 1985-04-22 |
| FR2338708A1 (fr) | 1977-08-19 |
| LU76616A1 (OSRAM) | 1977-07-27 |
| ES455137A1 (es) | 1977-12-16 |
| ATA38277A (de) | 1980-05-15 |
| SE426550B (sv) | 1983-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Grange et al. | Bovine tubercle bacilli and disease in animals and man | |
| Rotman et al. | Strongyloides stercoralis: eosinophil-dependent immune-mediated killing of third stage larvae in BALB/cByJ mice | |
| Sell | How vaccines work: immune effector mechanisms and designer vaccines | |
| KR101315092B1 (ko) | 로소니아 인트라셀룰라리스를 포함하는 면역원성 조성물 | |
| US4053582A (en) | Attenuated fowl pox virus preparation for the treatment of infectious diseases, method for the manufacture thereof, and its use | |
| JP6053036B2 (ja) | ウシ・ウイルス性下痢症ウイルス１ｂ型ワクチン組成物および方法 | |
| EP4137506A1 (en) | African swine fever vaccine composition | |
| US7707970B2 (en) | Vaccine against salmonid rickettsial septicaemia based on Arthrobacter cells | |
| BR112020010316A2 (pt) | cepa de vacina de brucella modificada para o tratamento de brucelose | |
| FI60408C (fi) | Foerfarande foer framstaellning av vaccin mot parvovirus-panleukopeni hos felider | |
| TW201731526A (zh) | 混成核心之貓科動物疫苗 | |
| Gudmundsdóttir et al. | Evaluation of cross protection by vaccines against atypical and typical furunculosis in Atlantic salmon, Salmo salar L. | |
| Van Heerden, KM* & Van Rensburg | The immunisation of rams against ovine brucellosis | |
| Kogut et al. | Evaluation of Salmonella enteritidis‐immune lymphokines on host resistance to Salmonella enterica ser. gallinarum infection in broiler chicks | |
| KR100825870B1 (ko) | 어류용의 이리도바이러스 감염증, 연쇄구균 감염증, 및이들의 합병증에 대한 혼합 불활성화 백신 | |
| CN114377127A (zh) | 一种三联卵黄抗体制剂及其制备方法和应用 | |
| JP2020529408A (ja) | ストレプトコッカス・スイスに対する防御のためのワクチン | |
| AU597709B2 (en) | Vaccines for fowl colibacillosis | |
| JP5240811B2 (ja) | マダイ滑走細菌症ワクチン及びマダイ滑走細菌症ワクチン組成物並びにマダイ滑走細菌症の予防法 | |
| Rickard et al. | Studies on the fate of Taenia hydatigena and Taenia ovis larvae in rabbits, and cross-immunity with Taenia pisiformis larvae | |
| Junge et al. | Clinical presentation and antiviral therapy for poxvirus infection in pudu (Pudu puda) | |
| RU2768749C1 (ru) | Средство специфической профилактики covid-19 для плотоядных животных | |
| RU2180238C1 (ru) | Биологический препарат для профилактики и лечения желудочно-кишечных и респираторных болезней телят | |
| Dorset et al. | Further experiments concerning the production of immunity from hog cholera | |
| JP7281208B2 (ja) | ＳｓｅＪタンパク質を用いたサルモネラワクチン |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: BEHRINGWERKE AKTIENGESELLSCHAFT |